Andrew Cooper

Stock Analyst at Raymond James

(3.00)
# 2,426
Out of 5,182 analysts
130
Total ratings
43.31%
Success rate
0.18%
Average return

Stocks Rated by Andrew Cooper

Azenta
Nov 25, 2025
Maintains: Outperform
Price Target: $35$45
Current: $25.15
Upside: +78.93%
Integer Holdings
Oct 24, 2025
Reiterates: Outperform
Price Target: $143$95
Current: $85.35
Upside: +11.31%
Avantor
Oct 16, 2025
Maintains: Outperform
Price Target: $14$16
Current: $7.97
Upside: +100.75%
Haemonetics
Aug 11, 2025
Downgrades: Outperform
Price Target: $105$78
Current: $60.48
Upside: +28.97%
Guardant Health
Jul 31, 2025
Maintains: Outperform
Price Target: $59$61
Current: $88.50
Upside: -31.07%
Revvity
Jul 29, 2025
Reiterates: Outperform
Price Target: $120$115
Current: $86.80
Upside: +32.49%
Thermo Fisher Scientific
Jul 24, 2025
Reiterates: Outperform
Price Target: $525$535
Current: $468.04
Upside: +14.31%
Myriad Genetics
May 7, 2025
Reiterates: Outperform
Price Target: $19$10
Current: $4.83
Upside: +107.04%
Fulgent Genetics
May 5, 2025
Reiterates: Outperform
Price Target: $24$25
Current: $15.60
Upside: +60.26%
UFP Technologies
Mar 28, 2025
Initiates: Market Perform
Price Target: n/a
Current: $197.30
Upside: -
Downgrades: Market Perform
Price Target: n/a
Current: $180.62
Upside: -
Downgrades: Market Perform
Price Target: n/a
Current: $21.85
Upside: -
Downgrades: Outperform
Price Target: $68$85
Current: $204.39
Upside: -58.41%
Downgrades: Outperform
Price Target: $100$76
Current: $12.29
Upside: +518.39%
Initiates: Market Perform
Price Target: n/a
Current: $4.46
Upside: -
Downgrades: Market Perform
Price Target: n/a
Current: $8.61
Upside: -
Downgrades: Market Perform
Price Target: n/a
Current: $33.85
Upside: -
Downgrades: Market Perform
Price Target: n/a
Current: $3.01
Upside: -